MedTrace Logo

Sequential Intrathecal Injection of Fentanyl and Hyperbaric Bupivacaine

NCT03415087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2018-01-30

No results posted yet for this study

Summary

56 Parturients, aged 18-40 year, undergoing elective CS were randomly assigned to receive sequential intrathecal injection of fentanyl and hyperbaric bupivacaine at the same rate (normal sequential) NS or a rapid intrathecal injection of fentanyl followed by slow injection of hyperbaric bupivacaine (rapid sequential) RS. Time of first rescue analgesia, Dose of rescue analgesics, degree of postoperative pain, incidence of hypotension, hypotension duration, ephedrine dose, spinal anaesthesia related complications and failed block were recorded.

Conditions

  • Elective Caesarean Section

Interventions

PROCEDURE

sequential intrathecal injection

intrathecal injection of fentanyl and hyperbaric bupivacaine

DRUG

hyperbaric bupivacaine

intrathecal injection of intrathecal bupivacaine

DRUG

fentanyl

intrathecal injection of fentanyl

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-07-01
Completion
2016-07-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03415087 on ClinicalTrials.gov